Ajay Sood, MD, PhD

Assistant Professor , Department of Neurological Sciences
Ajay Sood, MD, PhD
RUSH Medical College
Assistant Professor , Department of Neurological Sciences

Neurologist, Rush Alzheimer's Disease Center

Off

  • Ajay Sood, MD, PhD, is an assistant professor of Neurology with the Rush Alzheimer’s Disease Center. He completed Medical School at the University College of Medical Sciences (India), PhD in Pharmacology and Toxicology from Medical College of Georgia, Internship in Internal Medicine at Loyola University, Chicago, Neurology residency at Loyola University Chicago, and State University of New York, Syracuse. After completing his neurology residency, Sood received further training in Dementia and Alzheimer’s disease at Baylor University, Houston, TX. He is board-certified in Neurology and Psychiatry. Sood’s academic career interests include understanding the underlying mechanisms responsible for neurodegenerative conditions and advancing therapeutics in these conditions,  improving quality of care for patients suffering from dementia and associated conditions, and providing education and best care practices to community and physicians treating these conditions.

    After completing his education, Sood worked as a cognitive neurologist at AMITA Health, IL, for about five years, before joining the Rush Alzheimer’s Disease Center. He served as a principal investigator and sub-investigator for several pharmaceutical-sponsored, NIH-sponsored trials in dementia. Sood is also involved in epidemiological research at Rush Alzheimer’s Disease Center. He is also a part of the clinical care team to evaluate patients with various cognitive complaints at Rush memory center.

    Sood serves as a member of the Alzheimer’s Association’s Illinois chapter research committee and dementia working group international committee for ASPREE-XT. He is a member of the American Academy of neurology and Alzheimer’s association. He has authored/co-authored several manuscripts on Alzheimer’s disease and related dementia, including quality improvement parameters in patients with mild cognitive impairment (part of the AAN committee). He is currently involved in multiple projects involving dementia and Alzheimer’s disease.